ANIK - Anika Therapeutics, Inc.
14.28
-0.470 -3.291%
Share volume: 91,770
Last Updated: 03-27-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$14.75
-0.47
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-08-2024 | 11-04-2024 | 03-14-2025 | 05-09-2025 | 07-30-2025 | 11-05-2025 | 03-02-2026 | |
| Assets | |||||||||
| Total Assets | 263.744 M | 262.655 M | 231.405 M | 202.740 M | 190.605 M | 187.682 M | 189.437 M | 190.270 M | |
| Current Assets | 158.962 M | 155.000 M | 136.106 M | 113.652 M | 102.509 M | 99.317 M | 101.590 M | 103.358 M | |
| Inventories | 49.408 M | 51.464 M | 39.629 M | 23.809 M | 21.336 M | 16.922 M | 16.284 M | 18.787 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 32.077 M | 33.773 M | 28.357 M | 0.000 | 21.987 M | 23.955 M | 22.187 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 68.629 M | 62.822 M | 62.368 M | 55.629 M | 53.371 M | 53.167 M | 57.990 M | 57.481 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 46.057 M | 47.685 M | 44.572 M | 38.994 M | 40.461 M | 41.083 M | 40.684 M | 40.324 M | |
| Other Assets | 58.725 M | 59.970 M | 50.727 M | 50.094 M | 47.635 M | 47.282 M | 47.163 M | 46.588 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 263.744 M | 262.655 M | 231.405 M | 202.740 M | 190.605 M | 187.682 M | 189.437 M | 190.270 M | |
| Total liabilities | 55.208 M | 52.317 M | 51.541 M | 48.751 M | 42.208 M | 40.010 M | 42.632 M | 46.805 M | |
| Total current liabilities | 28.460 M | 26.121 M | 25.493 M | 23.306 M | 17.901 M | 16.081 M | 19.089 M | 21.908 M | |
| Accounts Payable | 10.022 M | 9.994 M | 6.805 M | 5.617 M | 5.277 M | 4.771 M | 4.732 M | 6.041 M | |
| Other liabilities | 26.748 M | 26.196 M | 26.048 M | 24.786 M | 24.307 M | 23.929 M | 23.543 M | 24.897 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 26.748 M | 26.196 M | 26.048 M | 24.786 M | 24.307 M | 23.929 M | 23.543 M | 24.897 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 208.536 M | 210.338 M | 179.864 M | 153.989 M | 148.397 M | 147.672 M | 146.805 M | 143.465 M | |
| Common stock | 91.313 M | 93.304 M | 92.033 M | 89.105 M | 87.706 M | 89.603 M | 91.249 M | 87.637 M | |
| Retained earnings | 123.538 M | 123.450 M | 93.532 M | 71.667 M | 66.794 M | 62.824 M | 60.495 M | 60.787 M |